A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab
Until recently, chemotherapy for metastatic melanoma had disappointing results. The identification of immune checkpoints such as CTLA-4 and PD-1/PD-L1 has led to the development of an array of monoclonal antibodies (Mabs). These immunologic approaches against tumoral cells come with a novel kind of...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2016-01-01
|
| Series: | Drug Target Insights |
| Online Access: | https://doi.org/10.4137/DTI.S31565 |